from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A reversible and selective inhibitor of monoamine oxidase B, used as an antiparkinsonian agent.


Sorry, no etymologies found.


  • Indeed Roche had developed the most advanced MAO-B inhibitor so far, lazabemide, which generated decent efficacy data in a phase III trial but was ditched by the Swiss group back in 1999 due to concerns over renal safety.


Log in or sign up to get involved in the conversation. It's quick and easy.